Sex and gender differences in myocarditis and dilated cardiomyopathy: An update
Frontiers in Cardiovascular Medicine · 02.03.2023 · 10
DOI: 10.3389/fcvm.2023.1129348 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 02.03.2023. Verfasst von DeLisa Fairweather und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, United States. Die Arbeit wurde bisher 131-mal zitiert (Crossref) und nennt 324 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
In the past decade there has been a growing interest in understanding sex and gender differences in myocarditis and dilated cardiomyopathy (DCM), and the purpose of this review is to provide an update on this topic including epidemiology, pathogenesis and clinical presentation, diagnosis and management. Recently, many clinical studies have been conducted examining sex differences in myocarditis. Studies consistently report that myocarditis occurs more often in men than women with a sex ratio ranging from 1:2–4 female to male. Studies reveal that DCM also has a sex ratio of around 1:3 women to men and this is also true for familial/genetic forms of DCM. Animal models have demonstrated that DCM develops after myocarditis in susceptible mouse strains and evidence exists for this progress clinically as well. A consistent finding is that myocarditis occurs primarily in men under 50 years of age, but in women after age 50 or post-menopause. In contrast, DCM typically occurs after age 50, although the age that post-myocarditis DCM occurs has not been investigated. In a small study, more men with myocarditis presented with symptoms of chest pain while women presented with dyspnea. Men with myocarditis have been found to have higher levels of heart failure biomarkers soluble ST2, creatine kinase, myoglobin and T helper 17-associated cytokines while women develop a better regulatory immune response. Studies of the pathogenesis of disease have found that Toll-like receptor (TLR)2 and TLR4 signaling pathways play a central role in increasing inflammation during myocarditis and in promoting remodeling and fibrosis that leads to DCM, and all of these pathways are elevated in males. Management of myocarditis follows heart failure guidelines and there are currently no disease-specific therapies. Research on standard heart failure medications reveal important sex differences. Overall, many advances in our understanding of the effect of biologic sex on myocarditis and DCM have occurred over the past decade, but many gaps in our understanding remain. A better understanding of sex and gender effects are needed to develop disease-targeted and individualized medicine approaches in the future.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, United States.
- Department of Environmental Health Sciences and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
- Center for Clinical and Translational Science, Mayo Clinic, Rochester, MN, United States.
- Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Jacksonville, FL, United States.
- Department of Cardiology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Division of Cardiovascular Medicine, Department of Medicine, University of Florida, Gainesville, FL, United States.
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- NCATS NIH HHS
- National Institutes of Health
- American Heart Association
Zitieren
APA
Fairweather, D., Beetler, D. J., Musigk, N., Heidecker, B., Lyle, M. A., Cooper, L. T., & Bruno, K. A. (2023). Sex and gender differences in myocarditis and dilated cardiomyopathy: An update. Frontiers in Cardiovascular Medicine, 10. https://doi.org/10.3389/fcvm.2023.1129348
Vancouver
Fairweather D, Beetler DJ, Musigk N, Heidecker B, Lyle MA, Cooper LT, et al. Sex and gender differences in myocarditis and dilated cardiomyopathy: An update. Frontiers in Cardiovascular Medicine. 2023;10. doi:10.3389/fcvm.2023.1129348
BibTeX
@article{Fairweather2023,
author = {Fairweather, DeLisa and Beetler, Danielle J and Musigk, Nicolas and Heidecker, Bettina and Lyle, Melissa A and Cooper, Leslie T and Bruno, Katelyn A},
title = {Sex and gender differences in myocarditis and dilated cardiomyopathy: An update},
journal = {Frontiers in Cardiovascular Medicine},
year = {2023},
volume = {10},
doi = {10.3389/fcvm.2023.1129348}
}
EUVIMED